Study of haematological, biochemical profile and clinical presentation in dengue positive patients: 82 cases

Clinical profile and predictors of Severe Dengue disease : A study from South India

Clinical profile of dengue hemorrhagic fever cases in Mexico.

OBJECTIVE Dengue hemorrhagic fever is a public health problem in Mexico since 1994. With four serotypes circulating the risk of epidemic dengue hemorrhagic fever is increasing. MATERIAL AND METHODS We describe the clinical features of confirmed cases in the social security health system (IMSS) from 1995 to 2003. Clinical picture and epidemiological features were compared and a multivariate mo...

Haematological and biochemical markers as predictors of dengue infection.

Dengue is a viral infection which has become a serious problem in recent years. It is a major cause of mortality and morbidity. The present study is a prospective, hospital-based, observational study done from August 2014 to October 2014. The objective of our study was to consider whether dengue infection can be suspected based on haematological and biochemical findings. The study included 100 ...

Dengue: profile of hematological and biochemical dynamics

AIM The objective of this study was to correlate laboratory tests during the evolution of dengue fever, comparing frequencies between the different clinical forms in order to use test results to predict the severity of the disease. METHODS This is an observational, descriptive and retrospective study of 154 patients with clinical and serological diagnoses of dengue fever who, in the period fr...

Study of clinical, haematological and cytogenetic profile of patients with acute erythroid leukaemia

BACKGROUND Acute erythroid leukaemia (AEL) is a rare subtype of acute myeloid leukaemia (AML), constituting <5% of all the cases of AML. The World Health Organization (WHO) in 2001 classified AEL into two types: (1) erythroid/myeloid leukaemia which required ≥50% erythroid precursors with ≥20% of the non-erythroid cells to be myeloid blasts and (2) pure erythroleukemia (pEL) with ≥80% erythrobl...